Navigation Links
NanoVibronix Receives Wound Healing Indications in Europe for its PainShield(TM) Device
Date:4/21/2009

NESHER, Israel, April 21 /PRNewswire/ -- NanoVibronix, a medical device company specializing in applications that implement surface ultrasound waves, announced that its novel device has received CE approval in Europe for additional claims of wound healing. PainShield is the first hands-free, patch-based device that uses surface ultrasound waves for therapeutic treatment of wounds. The innovative PainShield consists of a disposable patch connected to a portable driver. PainShield for wound therapy will be introduced at the upcoming European Wound Management Association (EWMA) conference in Helsinki, Finland on May 20 - 22, 2009.

"My experience with PainShield has shown that it is one of the most striking therapeutic modalities in chronic wound care. PainShield implements the benefits of ultrasound to enhance the therapeutic processes required for chronic wound healing, and has shown to do that repeatedly both in the clinical and home setting. ", stated Dr. Jonathan Rosenblum, Director, Diabetic Foot Service, Shaare Zedek Medical Center, Jerusalem, Israel. Dr. Rosenblum will be presenting his experience with PainShield for chronic wounds at the International Conference of Dermatology (ICD), Prague, Czech Republic on May 20 - 24, 2009.

Dr. Leon Gilad, Chief of Wound Care at Hadassah University Medical Center, Jerusalem, Israel, said, "The beneficial properties of low frequency, low intensity ultrasound in a compact, convenient patch allows for a whole new dimension in wound therapy. The ability to place the PainShield patch on healthy skin adjacent to the wound allows the ongoing wound care to continue uninterrupted, while therapeutic ultrasound is provided simultaneously to the wound site. In addition to the wound healing benefits of the PainShield, we have seen a dramatic diminishing of wound pain when pain was present."

NanoVibronix CEO, Dr. Harold Jacob, added, "PainShield, which implements
'/>"/>

SOURCE NanoVibronix Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused ... call on Thursday, August 14, 2014, at 4:30 p.m. Eastern ... 30, 2014. Financial results will be issued in a press ... and CEO James LaFrance will host the call, ... Thursday, August 14, 2014 Time: 4:30 p.m. Eastern time (3:30 ...
(Date:7/31/2014)... 2014  Today, Levi Ray & ... its PageCenterX ® content management solution. ... provide downtime reporting capabilities to healthcare organizations during ... the product for general availability, effective today. ... outages for a variety of reasons," said ...
(Date:7/31/2014)... WASHINGTON , July 31, 2014 ... is the first pharmacy in the nation to ... the leading health care accreditation organization that establishes ... CVS/pharmacy and Longs Drug Store locations nationwide have ... over 30 accreditation programs. Its Community Pharmacy Accreditation ...
Breaking Medicine Technology:Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014 2LRS Announces Downtime Reporting Solution for Healthcare 2CVS/pharmacy Earns First-Ever Community Pharmacy Accreditation from URAC 2CVS/pharmacy Earns First-Ever Community Pharmacy Accreditation from URAC 3
... Applied Precision is pleased to announce that Paul ... senior scientist, have been chosen to present a ... SPIE Photonics West.   Three-dimensional structured ... doubles the lateral and axial resolution, providing an ...
... 19, 2011 Throughout the playoffs and ... football fans a post season play at winning TemporalScanner™ ... time temperature before it is announced on national radio ... Star and Championship games can win an Exergen TemporalScanner. ...
Cached Medicine Technology:Applied Precision Scientific Team to Present 3D-SIM Paper at BiOS in San Francisco 2Exergen 'Game Time Temperature' Contest Helps Football Fans Tackle Cold and Flu Season 2Exergen 'Game Time Temperature' Contest Helps Football Fans Tackle Cold and Flu Season 3
(Date:7/31/2014)... (PRWEB) July 31, 2014 The rising ... major factor driving the global geriatric care services market ... the supply of these services across the globe. There ... a home care agency to few large companies with ... market is underserved and is also highly fragmented. The ...
(Date:7/31/2014)... bipartisan support would allow Medicare to test a concept ... the health of patients with chronic illness while reducing ... need most. , The bill, introduced last week by ... of a decade of work by health policy researchers ... Innovation. It would allow Medicare Advantage plans to use ...
(Date:7/31/2014)... The Never Give Up 26 Foundation looks forward ... 7th. Simply bring your ticket and Mention Never Give ... with friends and family. , Packy had unique ... and contagious optimism continues to impact the lives of many. ... to pursue a happy life was truly a testament to ...
(Date:7/31/2014)... to a new market research report, the "Inertial Navigation ... Asia-Pacific, the Middle East, and ROW) - Forecast & ... estimated at $2.75 billion in 2014 and is expected ... system market for defense segment is estimated at $1.98 ... billion by 2019. The inertial navigation system market for ...
(Date:7/31/2014)... In what is believed to be the largest genetic ... growth in a common childhood blood cancer, researchers at ... a possible new drug target for treating the disease. ... the most common and aggressive childhood blood cancers. An ... diagnosed with the cancer each year in the U.S. ...
Breaking Medicine News(10 mins):Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 2Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 3Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 4Health News:Geriatric Care Services Market (Home Care, Adult Day Care, and Institutional Care): Global Industry Analysis, Size, Share, Growth, Forecast 2013 - 2019 5Health News:Don't Forget To Mention Never Give Up 26 Foundation 2Health News:Inertial Navigation System Market Worth $4.63 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Inertial Navigation System Market Worth $4.63 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Inertial Navigation System Market Worth $4.63 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Inertial Navigation System Market Worth $4.63 Billion by 2019 - New Report by MarketsandMarkets 5Health News:Drug target identified for common childhood blood cancer 2Health News:Drug target identified for common childhood blood cancer 3
... Sports Producer Michael Weisman and Wife ... ... Lupus Foundation,s,"Life Without Lupus" Gala raised more than $3.2 million for lupus, ... services, and nurture research for the chronic and often,devastating autoimmune illness. Nearly ...
... on Four Phase 2 Clinical Trials,Dow AgroSciences CEO Discusses ... 5 Sangamo BioSciences, Inc.,(Nasdaq: SGMO ) announced ... in 2007 and preview objectives for 2008 during its,annual ... today., Jerome Peribere, President and CEO of Dow ...
... Md., Dec. 5 An array of toolkits,designed ... others,reduce medical errors was released today by HHS, ... toolkits, developed by AHRQ-funded experts who specialize in,patient ... be adapted,to most health care settings. The toolkits ...
... can be inherited from both parents, scientists say , WEDNESDAY, ... nine genetic markers that can increase a person,s risk for ... be inherited in what geneticists call a "recessive" manner -- ... copies of these markers from each parent, his or her ...
... Fl., December 5, 2007 Data from two Phase ... medication that belongs to the class of agents known ... treatment for patients with all extents of ulcerative colitis ... patients with isolated proctitis who took Asacol, dosed at ...
... Caraco Pharmaceutical,Laboratories, Ltd., (Amex: CPD ) ... (FDA) has granted final approval for the Company,s,Abbreviated ... mg, 5 mg, and 10 mg (Amlodipine)., ... for the,symptomatic treatment of chronic stable angina, and ...
Cached Medicine News:Health News:S.L.E. Lupus Foundation Gala Raises Record $3.2 Million for Lupus 2Health News:Sangamo BioSciences Provides Update on Company's Accomplishments in 2007 and 2008 Objectives 2Health News:Sangamo BioSciences Provides Update on Company's Accomplishments in 2007 and 2008 Objectives 3Health News:Sangamo BioSciences Provides Update on Company's Accomplishments in 2007 and 2008 Objectives 4Health News:Sangamo BioSciences Provides Update on Company's Accomplishments in 2007 and 2008 Objectives 5Health News:Sangamo BioSciences Provides Update on Company's Accomplishments in 2007 and 2008 Objectives 6Health News:Sangamo BioSciences Provides Update on Company's Accomplishments in 2007 and 2008 Objectives 7Health News:AHRQ Releases Toolkits to Help Providers and Patients Implement Safer Health Care Practices 2Health News:Genes Yield More Clues to Schizophrenia 2Health News:Asacol treats UC symptoms of isolated proctitis 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Norvasc(R) 2
... Proclear Multifocal are the only contact lenses ... by those with aging eyes: presbyopia and ... combine a superior lens design, Balanced Progressive ... using our patented PC Technology. The result? ...
... features a smooth, flat tip extending from ... The uniquely designed tip is used to ... endangering the posterior capsule. The end ... oval sideports help avoid surge should the ...
Designed with your input, the ATS Simulus™ flexible annuloplasty ring and band are easy endings to complex mitral valve repairs....
The Victory single- and dual-chamber rate-responsive pacemakers from St. Jude Medical are advanced-feature systems, designed to save valuable clinic time, maximize patient safety, and provide other t...
Medicine Products: